TREO Abdominal Stent-Graft System 28-C2-30-055URecalls & reported problems
Bolton Medical Inc. · Endovascular Stent-Graft System · Class 3 · Implant
All models of TREO Abdominal Stent-Graft System (73)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00843576152694), received between Nov 25, 2024 and Nov 25, 2024 — classified as 1 injury.
The most frequently reported specific device problem is “Device Endoleak” (1 report).
1 other recall cover devices cleared under the same FDA submission (P190015); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Device Endoleak1
- Failure to Seal1
Patient problems
- Clinical Endoleak1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryNov 25, 2024Failure to Seal; Device Endoleak; Failure to Seal; Device Endoleak
"EVALUATED A CT SCAN FOR DR. (B)(6) ON (B)(6) 2024. ENDOLEAK WAS NOTED ON THE SCAN. POTENTIAL TYPE 3, 1A OR 2. SOURCE WAS TO BE DETERMINED POST SELECTIVE ANGIOGRAMS SCHEDULED ON (B)(6) 2023. PER MY DISCUSSION WITH DR. (B)(6), THE INITIAL TREO GRAFT WAS IMPLANTED 1CM DISTAL TO THE TAKEOFF THE LRA IN 2021. DURING THE INITIAL ANGIOGRAM PERFORMED ON (B)(6) 2025, BRISK FILLING ON THE ANEURYSM SAC WAS NOTED. DR. (B)(6) MADE THE DECISION TO PLACE A TREO CUFF TO THE LEVEL OF THE LRA (30MM X 55MM). THEREAFTER, IT WAS MOLDED USING THE CODA BALLOON AND ANOTHER ANGIOGRAM WAS TAKEN. THIS ANGIO STILL REVEALED THE LEAK. THEN THE DECISION WAS MADE TO LEAVE THE CODA BALLOON INFLATED IN THE PROXIMAL SEGMENT OF THE GRAFT/CUFF AND PLACE THE PIGTAIL CATHETER DISTAL TO THE BALLOON AND ABOVE THE FLOW-DIVIDER OF THE GRAFT. DURING THIS INJECTION, WE NOTED THE JETTING OF CONTRAST ON THE RIGHT MEDIAL SIDE OF THE TREO MAIN BODY GRAFT THROUGH THE FABRIC. THIS CONFIRMED THE TYPE 3B ENDOLEAK. DR. (B)(6) DECIDED TO CONFIRM THIS FINDING BY TAKING A BERNSTEIN CATHETER AND WAS ABLE TRAVERSE THE CATHETER THROUGH THE FABRIC TEAR OF THE GRAFT AND THEREAFTER PLACING A WIRE THROUGH THE CATHETER INTO THE ANEURYSM SAC. WAI
Patient problems: Clinical Endoleak
MAUDE report 20771515 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P190015. One submission often covers many models, so check the product and lot details in each record.
- Z-1689-2023 · May 3, 2023 · Open, ClassifiedThe TREO ABDOMINAL STENT-GRAFT SYSTEM (TREO) consists of four types of implants, specifically a Main Bifurcated Stent-Graft, a Leg Extension Stent-Graft, a Proximal Cuff Stent-Graf
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page